De Braud Filippo Guglielmo Maria

The Pan-Immune-Inflammation Value in microsatellite instability-high metastatic colorectal cancer patients treated with immune checkpoint inhibitors / F. Corti, S. Lonardi, R. Intini, M. Salati, E. Fenocchio, C. Belli, B. Borelli, M. Brambilla, A.A. Prete, V. Quarà, M. Antista, M. Fassan, F. Morano, A. Spallanzani, M. Ambrosini, G. Curigliano, F. de Braud, V. Zagonel, G. Fucà, F. Pietrantonio. - In: EUROPEAN JOURNAL OF CANCER. - ISSN 0959-8049. - 150(2021 Apr 23), pp. 155-167.

Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Locally Advanced or Metastatic ROS1 Fusion-Positive Non-Small-Cell Lung Cancer / R. Dziadziuszko, M.G. Krebs, F. De Braud, S. Siena, A. Drilon, R.C. Doebele, M.R. Patel, B.C. Cho, S.V. Liu, M. Ahn, C. Chiu, A.F. Farago, C. Lin, C.S. Karapetis, Y. Li, B. Day, D. Chen, T.R. Wilson, F. Barlesi. - In: JOURNAL OF CLINICAL ONCOLOGY. - ISSN 0732-183X. - 39:11(2021 Apr 10), pp. JCO2003025.1253-JCO2003025.1263.

Prognostic impact of early tumor shrinkage and depth of response in patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitors / G. Fucà, F. Corti, M. Ambrosini, R. Intini, M. Salati, E. Fenocchio, P. Manca, C. Manai, F. Daniel, A. Raimondi, F. Morano, S. Corallo, M. Prisciandaro, A. Spallanzani, V. Quarà, C. Belli, M. Vaiani, G. Curigliano, C. Cremolini, F. De Braud, M. Di Bartolomeo, V. Zagonel, S. Lonardi, F. Pietrantonio. - In: JOURNAL FOR IMMUNOTHERAPY OF CANCER. - ISSN 2051-1426. - 9:4(2021 Apr).

Beyond first-line immunotherapy: Potential therapeutic strategies based on different pattern progressions: Oligo and systemic progression / A. Prelaj, C.C. Pircher, G. Massa, V. Martelli, G. Corrao, G.L. Russo, C. Proto, R. Ferrara, G. Galli, A. De Toma, C. Genova, B.A. Jereczek-Fossa, F. de Braud, M.C. Garassino, S.E. Rebuzzi. - In: CANCERS. - ISSN 2072-6694. - 13:6(2021 Mar 15), pp. 1300.1-1300.22.

Impact of baseline and on-treatment glycemia on everolimus-exemestane efficacy in patients with hormone receptor-positive advanced breast cancer (EVERMET) / C. Vernieri, F. Nichetti, L. Lalli, L. Moscetti, C.A. Giorgi, G. Griguolo, A. Marra, G. Randon, C.G. Rea, F. Ligorio, S. Scagnoli, C. De Angelis, C. Molinelli, A. Fabbri, E. Ferraro, D. Trapani, A. Milani, E. Agostinetto, O. Bernocchi, G. Catania, A. Vantaggiato, M. Palleschi, A. Moretti, D. Basile, M. Cinausero, A. Ajazi, L. Castagnoli, S. Lo Vullo, L. Gerratana, F. Puglisi, N. La Verde, G. Arpino, A. Rocca, M. Ciccarese, R. Pedersini, A. Fabi, D. Generali, A. Losurdo, F. Montemurro, G. Curigliano, L. Del Mastro, A. Michelotti, E. Cortesi, V. Guarneri, G. Pruneri, L. Mariani, F. de Braud. - In: CLINICAL CANCER RESEARCH. - ISSN 1078-0432. - (2021). [Epub ahead of print]